Oculus Innovative Sciences, Inc. (OCLS) Announces Latin American Regulatory Approvals for Microcyn-Based Antiseptic Products
Global healthcare company Oculus Innovative Sciences recently announced new regulatory approvals in Panama and El Salvador for its Microcyn-based antiseptic products under the brand name Microdacyn. The growth of the company’s Microcyn-based product portfolio, along with its international footprint, has happened synergistically. As Oculus works closely with strong global partners, including its Latin-American partner More Pharma, the company has been continuously announcing new regulatory approvals, new products, and new territories to serve. Ultimately, the availability of Oculus’ Microcyn technology will benefit an expanded global population. More Pharma plans to begin commercialization of Oculus’ new antiseptic products in Panama and El…